About 95% of the world's population is infected with EBV. During the initial infection, the virus may cause infectious mononucleosis, only minor non-specific symptoms, or no symptoms. Regardless of this, the virus enters a latency phase and the infected individual becomes a lifetime asymptomatic carrier of EBV.
About 95% of the global population is affected by EBV. During the initial infection, the virus may cause infectious mononucleosis, minor symptoms, or no signs of illness. Consequently, the virus enters a latent phase and the infected individual becomes a lifelong asymptomatic host for EBV.